Clinical Trial

Anakinra for Preterm Infants Pilot

Active, Not Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
Phase I/II study of anakinra to prevent the impact of perinatal inflammation in extremely premature infants.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-03-12; most recent amendment 2024-09-15.
Status change: Recruiting → Active, Not Recruiting 2024-09-15
Trial Details
NCT Number NCT05280340
Lead Sponsor Monash Medical Centre
Collaborators: Monash University, Hudson Institute of Medical Research, Te Whatu Ora - Health New Zealand, University of Auckland, New Zealand
Conditions Prematurity; Extreme, Inflammation
Enrollment 25 participants
Start Date 2022-02-15
Primary Completion 2024-03-21 (estimated)
Study Completion 2025-03 (estimated)
Updated on ClinicalTrials.gov 2024-09-19